Skip to main content
Article thumbnail
Location of Repository

Structure/Function Studies of the P2X Receptor

By Helen Digby


P2X receptors are a novel family of ligand-gated ion channels that open in response to the binding of extracellular ATP. There are no crystal structures available for the P2X receptor family and they share little homology with other ATP-binding proteins. For this reason, experimental evidence has been relied upon to determine the topology of the P2X receptor family and infer function. The family presents numerous drug targets for the treatment of cystic fibrosis, regulation of blood pressure, pain and irritable bowel syndrome to name a few (Khakh & North, 2006). A better understanding of the structure of P2X receptors gained through mutagenesis and more recently bioinformatic techniques will enable better drug design and development.\ud The amino acid sequence of a protein determines its secondary structure which in turn dictates the tertiary or 3D structure. Protein function is dependent on protein structure and for this reason structural studies can give important insight into protein function. Alanine-replacement of conserved glycine residues in the P2X receptor family has been studied to determine the impact of the flexible nature of glycine in the extracellular segment of the P2X1 receptor. A key functional residue, glycine-250 (P2X1 receptor numbering), was identified and its predicted location at the C-terminal end of an a-helix confirms such a role. However, it is not possible to predict the tertiary structure of a protein based on amino acid sequence alone; the so-called ‘protein-folding problem’. Therefore, this thesis has relied upon sequence analysis and protein structure prediction methods as tools for extracting structural information from P2X receptor sequences. In particular, searching for structural templates on which to model both the putative ligand-binding segment of the P2X1 receptor and the newly defined cysteine-rich domain of the extracellular segment.\ud Published homology models for the rat P2X4 receptor using class II aminoacyl-tRNA synthetases as structural templates exist. Such models have been validated by mutagenesis studies and residues thought to be important in ATP-binding at the P2X4 receptor have been identified. These residues have been aligned to the hP2X1 receptor sequence and the corresponding residues mutated to cysteine. It is clear that this P2X4 receptor model does not directly translate as a model of ATP-binding at the hP2X1 receptor due to inconsistencies in mutagenesis data and the unreliable nature of the original homology model. In contrast, a model of ATP-binding at the P2X1 receptor based on experimental data does provide an interesting insight into those residues involved in ATP-binding at the P2X4 receptor thus enhancing the published homology models and validating the P2X1 receptor models of ATP-binding

Publisher: University of Leicester
Year: 2007
OAI identifier:

Suggested articles


  1. (2004). 3DCoffee@igs: a web server for combining sequences and structures into a multiple sequence alignment.
  2. (2006). A C-terminal lysine that controls human P2X4 receptor desensitization.
  3. (1998). A domain contributing to the ion channel of ATP-gated P2X2 receptors identified by the substituted cysteine accessibility method.
  4. (1996). A flexible motif search technique based on generalized profiles.
  5. (2001). A glia-derived acetylcholine-binding protein that modulates synaptic transmission.
  6. (2003). A graph-theory algorithm for rapid protein side-chain prediction.
  7. (1992). A new approach to protein fold recognition.
  8. (1994). A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP.
  9. (1995). A P2X purinoceptor cDNA conferring a novel pharmacological profile.
  10. (1995). A P2X purinoceptor expressed by a subset of sensory neurons.
  11. (2000). A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels.
  12. (2003). A role of the fast ATP-gated P2XI cation channel in thrombosis of small arteries in vivo.
  13. (2002). A study of P2XI receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors.
  14. (2002). A two-stage SVM architecture for predicting the disuffide bonding state of cysteines.
  15. (1996). A unifying purinergic hypothesis for the initiation of pain.
  16. (2001). Adenosine 5-triphosphate Physiol Rev 81,767-806. a P2-purinergic agonist in the myocardium.
  17. (1979). Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.
  18. (2000). AG protein-coupled receptor for UDP-glucose. JBiol Chem
  19. (2004). Altered ATP-sensitive P2 rýeceptor subtype expression in the Han: SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease. Cells Tissues Organs 178,168-179.
  20. (2001). Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X(2) receptor.
  21. (1992). Amino acid substitution matrices from protein blocks.
  22. (2004). Amino acid substitutions from an indispensable disulfide bond affect P2X2 receptor activation.
  23. (2001). Aminoacyl-tRNA synthetases database.
  24. (1998). An aspartic acid residue near the second transmembrane segment of ATP receptor/channel regulates agonist sensitivity.
  25. (1978). Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.
  26. (2005). Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize.
  27. (2004). ATP binding at human P2XI receptors. Contribution of aromatic and basic amino acids revealed using mutagenesis and partial agonists.
  28. (1998). ATP binding site of P2X channel proteins: structural similarities with class 11 aminoacyl-tRNA synthetases.
  29. (1998). ATP derivatives are antagonists of the P2Yl receptor: similarities to the platelet ADP receptor. Mol Pharmacol 53,727-733. Henikoff S& Henikoff JG.
  30. (1983). ATP excites a subpopulation of rat dorsal hom neurones.
  31. (1993). ATP--a fast neurotransmitter.
  32. (1990). ATP-activated channels in rat and bullfrog sensory neurons: concentration dependence and kinetics.
  33. (2001). ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease.
  34. (1997). Baculovirus expression provides direct evidence for heteromeric assembly of P2X2 and P2X3 receptors.
  35. (1990). Basic local alignment search tool.
  36. (2000). beta-subunits of Snfl kinase are required for kinase function and substrate definition.
  37. (2001). Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins.
  38. (1999). CAFASP-1: critical assessment of fully automated structure prediction methods.
  39. (1963). Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow.
  40. (1998). Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor.
  41. (1995). Characterization and chromosomal localization of a human P2X receptor from the urinary bladder. Receptors Channels 3,283-289.
  42. (1988). Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery.
  43. (1997). Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue.
  44. (1986). Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
  45. (1998). CINEMA--a novel colour INteractive editor for multiple alignments.
  46. (1997). Cloned ligand-gated channels activated by extracellular ATP (P2X receptors).
  47. (2000). Cloning and characterization of Hunk, a novel mammalian SNF I -related protein kinase.
  48. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor.
  49. (1997). Cloning of P2XM, a novel human P2X receptor gene regulated by p53.
  50. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positionspecific gap penalties and weight matrix choice.
  51. (1998). Co-expression of P2XI and P2X5 receptor subunits reveals a novel ATP-gated ion channel.
  52. (1995). Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons.
  53. (1993). Comparative protein modelling by satisfaction of spatial restraints.
  54. (1994). Conformational characteristics of asparaginyl residues in proteins.
  55. (2002). Conserved Cysteine Residues in the Extracellular Loop of the Human P2XI Receptor Form Disulfide Bonds and Are Involved in Receptor Trafficking to the Cell Surface.
  56. (2004). Conserved gating hinge in ligand- and voltage-dependent K+ channels.
  57. (2001). Conserved Negatively Charged Residues Are Not Required for ATP Action at P2X I Receptors.
  58. (2005). Contribution of conserved glycine residues to ATP action at human P2XI receptors: mutagenesis indicates that the unique property of glycine at position 250 is important for channel function.
  59. (2006). Contribution of conserved polar glutamine, asparagine and threonine residues and glycosylation to agonist action at human P2XI receptors for ATP doi: 10.111 I/j. 1471-4159.2005.03593. x.
  60. (1999). Contribution of individual subunits to the multimeric P2X(2) receptor: estimates based on methanethiosulfonate block at T336C. Mol Pharmacol 56,973-
  61. (2005). Contribution of transmembrane regions to ATP-gated P2X2 channel permeability dynamics.
  62. (1999). Contributions of the C-terminal domain to the control of P2X receptor desensitization.
  63. (2001). Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
  64. (1999). Crystal structure of UvrB, a DNA helicase adapted for nucleotide excision repair.
  65. (1994). Crystal structures at 2.5 angstrom resolution of seryl-tRNA synthetase complexed with two analogs of seryl adenylate.
  66. (2007). Cysteine substitution mutants give structural insight and identify ATP binding and activation sites at P2X receptors.
  67. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y I -deficient mice.
  68. (2003). Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport.
  69. (1999). Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(l) receptor-null mice.
  70. (1994). Detection of conserved segments in proteins: iterative scanning of sequence databases with alignment blocks.
  71. (1996). Deviations from standard atomic volumes as a quality measure for protein crystal structures.
  72. (2001). Differential assembly of rat purinergic Mýsub 17 receptor in immune cells of the brain and periphery 10.1074/jbc. MI02253200. JBiol Chem,
  73. (1996). Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry.
  74. (1998). Dissecting &agr; -helices: Position-specific analysis of &agr; -helices in globular proteins.
  75. (1982). Distantly related sequences in the alpha- and betasubunits of ATP synthase, myosin, kinases and other ATP requiring enzymes and a common nucleotide binding fold.
  76. (1996). distribution and properties of an extended family of ATP-gated ion channels.
  77. (2004). Disuffide connectivity prediction using recursive neural networks and evolutionary information.
  78. (2006). DISULFIND: a disulfide bonding state and cysteine connectivity prediction server.
  79. (1976). Do some nerve cells release more than one transmitter?
  80. (1982). Does ATP cross the cell plasma membrane.
  81. (1996). Domains of P2X receptors involved in desensitization.
  82. (1994). Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates.
  83. (1996). Errors in protein structures. Nature 381, 272. hLtRj/L/ww Lw. n leg ýb i. n ILum. n ii Lh-Z ov ýL/BLA,
  84. (2003). ESPript/ENDscript: Extracting and rendering sequence and 3D information from atomic structures of proteins.
  85. (1990). Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides.
  86. (1993). Expression cloning of an ATP receptor from mouse neuroblastorna cells.
  87. (1996). Extracellular ATP as a neurotransmitter: its role in synaptic plasticity in the hippocampus. Acta Neurobiol Exp (Wars)
  88. (2003). Extracellular ATP as a signalling molecule for epithelial cells.
  89. (2002). Fully automated ab initio protein structure prediction using ISITES, HMMSTR and ROSETTA.
  90. (1999). Functional and biochemical evidence for heteromeric ATP-gated channels composed of P2XI and P2X5 subunits.
  91. (2000). Functional properties of heteromeric P2X(1/5) receptors expressed in HEK cells and excitatory junction potentials in guinea-pig submucosal arterioles. JAuton Nerv Syst 81,249-263.
  92. (2006). Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin.
  93. (1991). Further subclassification of ATP receptors based on agonist studies.
  94. (2004). Gain and loss of channel function by alanine substitutions in the transmembrane segments of the rat ATP-gated P2X2 receptor.
  95. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
  96. (1999). Glycyl-tRNA synthetase uses a negatively charged pit for specific recognition and activation of glycine.
  97. (2004). Heterogeneity of P2X receptors in sympathetic neurons: contribution of neuronal P2XI receptors revealed using knockout mice.
  98. (2003). Histidine 140 plays a key role in the inhibitory modulation of the P2X4 nucleotide receptor by copper but not zinc.
  99. (1999). Identification of a domain involved in ATP-gated ionotropic receptor subunit assembly.
  100. (2002). Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor.
  101. (1994). Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit.
  102. (2000). Identification of Amino Acid Residues Contributing to the ATP-binding Site of a Purinergic P2X Receptor.
  103. (1997). Identification of amino acid residues contributing to the pore of a P2X receptor.
  104. (2007). Identification of an intersubunit cross-link between substituted cysteine residues located in the putative ATP binding site of the P2X I receptor.
  105. (2001). Identification of the platelet ADP receptor targeted by antithrombotic drugs.
  106. (1990). Improvements in protein secondary structure prediction by an enhanced neural network.
  107. (2000). Improving the quality of twilight-zone aligmments.
  108. (1988). Indications for P2-purinoceptor subtypes in guinea pig smooth muscle.
  109. (2001). Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit.
  110. (1991). Influence of proline residues on protein confon-nation.
  111. (1986). Information content of binding sites on nucleotide sequences.
  112. (2003). Interaction between cysteines introduced into each transmembrane domain of the rat P2X2 receptor.
  113. (2005). Investigating the putative glycine hinge in Shaker potassium channel.
  114. (1989). Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides.
  115. (1985). Is there a basis for distinguishing two types of P2-punnoceptor?
  116. (1987). Knowledge based modelling of homologous proteins, Part 1: Three-dimensional frameworks derived from the simultaneous superposition of multiple structures.
  117. (2000). Large-scale comparison of protein sequence alignment algorithms with structure alignments.
  118. (1984). Limit distribution of maximal non-aligned twosequence segmental score.
  119. (1996). Local alignment statistics.
  120. (2000). Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
  121. (2000). Mechanisms for activation and antagonism of an AMPAsensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
  122. (1968). Membrane adenosine triphosphatase and cation transport.
  123. (2000). Modeling of loops in protein structures.
  124. (2003). Modeller: generation and refinement of homology-based protein structure models.
  125. (1999). Molecular and functional characterization of human P2X(2) receptors.
  126. (1997). Molecular characterization and pharmacological properties of the human P2X3 purinoceptor.
  127. (1992). Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
  128. (2005). Molecular Determinants of the Agonist Binding Domain of a P2X Receptor Channel.
  129. (2002). Molecular Physiology of P2X Receptors.
  130. (2004). Molecular properties of ATP-gated P2X receptor ion channels.
  131. (2006). Molecular properties of P2X receptors. Pflugers Arch.
  132. (2004). Molecular structure of P2X receptors.
  133. (2003). Monomeric and dimeric byproducts are the principal functional elements of higher order P2XI concatamers.
  134. (2005). MSDsite: a database search and retrieval system for the analysis and viewing of bound ligands and active sites.
  135. (1992). Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels.
  136. (2005). Mutagenesis studies of conserved proline residues of human P2X receptors for ATP indicate that proline 272 contributes to channel function.
  137. (2000). Mutation of histidine 286 of the human P2X4 purinoceptor removes extracellular pH sensitivity.
  138. (2002). Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor.
  139. (1999). Neighboring glycine residues are essential for P2X2 receptor/channel function.
  140. (1999). Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds.
  141. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
  142. (2000). Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40,431-458.
  143. (2005). Non-canonical YXXGPhi endocytic motifs: recognition by AP2 and preferential utilization in P2X4 receptors.
  144. (2003). Overexpression of the platelet P2XI ion channel in transgenic mice generates a novel prothrombotic phenotype.
  145. (2005). P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death.
  146. (2000). P2X receptor expression in mouse urinary bladder and the requirement of P2XI receptors for functional P2X receptor responses in the mouse urinary bladder smooth muscle.
  147. (2006). P2X receptors as cell-surface ATP sensors in health and disease.
  148. (1995). P2X receptors bring new structure to ligandgated ion channels. Trends in Neurosciences 18,224-229.
  149. (1996). P2X receptors: a third major class of ligand-gated ion channels. Ciba Found Symp 198,91-105; discussion
  150. (1996). P2X receptors: an emerging channel family.
  151. (2003). P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury.
  152. (1998). P2XI and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion cbannels.
  153. (2003). P2XI receptor currents after dis ption of the ru PKC site and its surroundings by dominant negative mutations in HEK293 cells.
  154. P2XI Receptor Subunit Contribution to Gating Revealed by a Dominant Negative PKC Mutant.
  155. (2002). P2XI Receptor-Deficient Mice Establish the Native P2X Receptor and a P2Y6-Like Receptor in Arteries.
  156. (1990). Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs.
  157. (2005). PDB-Ligand: a ligand database based on PDB for the automated and customized classification of ligand-binding structures.
  158. (2006). Pharmacology of P2X channels.
  159. (1994). PHD--an automatic mail server for protein secondary structure prediction.
  160. (1996). PHD: predicting one-dimensional protein structure by profile-based neural networks.
  161. (2002). Point mutations confer loss of ATP-induced human P2X(7) receptor function.
  162. (2001). Polar residues of the second transmembrane domain influence cation permeability of the ATP-gated P2X(2) receptor.
  163. (2002). Potential therapeutic targets in the rapidly expanding field of purinergic signalling.
  164. (2003). Predicting the disulfide bonding state of cysteines with combinations of kernel machines.
  165. (1993). Prediction of protein secondary structure at better than 70% accuracy.
  166. (1978). Prediction of the secondary structure of proteins from their amino acid sequence.
  167. (1997). Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system.
  168. (1998). Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct.
  169. (1993). PROCHECK: a program to check the stereochemical quality of protein structures.
  170. (1987). Profile analysis: detection of distantly related proteins.
  171. (1996). ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem Soc Trans 24,274-279,
  172. (1990). Protein database searches for multiple alignments.
  173. (2003). Protein Ligand Database (PLD): additional understanding of the nature and specificity of protein-ligand complexes.
  174. (1997). Protein secondary structure prediction using local alignments.
  175. (2001). Punnergic signalling: ATP release.
  176. (1972). Purinergic nerves.
  177. (1995). Purinoceptors in the nervous system.
  178. (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther
  179. (1983). Random sequences.
  180. (1994). Rapid and accurate estimates of statistical significance for sequence data base searches.
  181. (2003). RASCAL: rapid scanning and correction of multiple sequence alignments.
  182. (1983). Receptor for ATP in the membrane of mammalian sensory neurones.
  183. (1998). Receptors for purines and pyrimidines.
  184. (1999). Recognition of remote protein homolgies using three-dimensional information to generate a Position specific scoring matrix in the program 3D-PSSM.
  185. (2000). Reduced vas deferens contraction and male infertility in mice lacking P2X I receptors.
  186. (2004). Renal autoregulation in P2XI knockout mice.
  187. (2006). Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor.
  188. (2004). Role of extracellular histidines in agonist sensitivity of the rat P2X4 receptor.
  189. (2000). Roles of individual N-glycans for ATP potency and expression of the rat P2X I receptor.
  190. (1994). Rules for alpha-helix termination by glycine.
  191. (2000). Saturated BLAST: an automated multiple intermediate sequence search used to detect distant homology.
  192. (2000). SAWTED: structure assignment with text description- -enhanced detection of remote homologues with automated SWISSPROT annotation comparisons.
  193. (1996). SeaView and Phylo-win, two graphic tools for sequence alignment and molecular phylogeny.
  194. (1996). Signalling by extracellular nucleotides.
  195. (1999). Single channel properties of P2X2 purinoceptors.
  196. (1963). Stereochernistry of polypeptide chain configurations.
  197. (1997). Structural motif and characteristics of the extracellular domain of P2X receptors.
  198. (2004). Structure and function of AMPA receptors.
  199. (1998). Structure of a glutamate-receptor ligand-binding core in complex with kainate.
  200. (1980). Subclasses of external adenosine receptors.
  201. (2003). Subunit arrangement in P2X receptors.
  202. (2003). SWISS-MODEL: An automated protein homology-modeling server.
  203. (2000). The 2.0 A crystal structure of Thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules.
  204. (1980). The aL conformation at the ends of helices.
  205. (1981). The anatomy and taxonomy of protein structure.
  206. (1995). The class 11 aminoacyl-tRNA synthetases and their active site: evolutionary conservation of an ATP binding site.
  207. (1997). The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
  208. (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).
  209. (2003). The effects of activation and blockade of central P2X receptors on body temperature.
  210. (1999). The enigmatic megakaryocyte gradually reveals its secrets.
  211. (1990). The fifth Heymans memorial lecture-Ghent,
  212. (1997). The first step of am, noacylation at the atomic level in histidyl-tRNA synthetase.
  213. (2001). The first transmembrane domain of the P2X receptor subunit participates in the agonist-induced gating of the channel.
  214. (1994). The functions and consensus motifs of nine types of peptide segments that form different types of nucleotide-binding sites.
  215. (2004). The Jalview Java alignment editor.
  216. (1959). The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves.
  217. (1998). The macro- and microarchitectures of the ligand-binding domain of glutamate receptors.
  218. (2005). The mechanism by which ethanol inhibits rat P2X(4) receptors is altered by mutation of histidine 24 1. Br
  219. (2006). The monomers of the P2XI receptor model and KcsA protein share a similar structural fold.
  220. (2004). The nucleotide-binding domain of the Zn2+-transporting P-type ATPase from Escherichia coli carries a glycine motif that may be involved in binding of ATP.
  221. (2005). The P2 receptors in platelet function.
  222. (1997). The P2Y I receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
  223. (1997). The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36,1127-1139. Burnstock G. (200 1). Purine-mediated signalling in pain and visceral perception.
  224. (1997). The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA.
  225. (2000). The Protein Data Bank.
  226. (2000). The PSIPRED protein structure prediction server. Bioinformatics 16,404-405. Meyerhof
  227. (2003). The Q motif- a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis.
  228. (2005). The Ramachandran plots of glycine and pre-proline.
  229. (2000). The Role of Positively Charged Amino Acids in ATP Recognition by Human P2X I Receptors.
  230. (1997). The structure, function and distribution of the mouse TWIK- I K+ channel.
  231. (2000). The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000.
  232. (1993). TMbase-A database of membrane spanning proteins segments.
  233. (1995). TOPITS: threading one-dimensional predictions into three-dimensional structures.
  234. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci 2,1511-1519. Communi Dý
  235. (2005). Visualization of the trimeric P2X2 receptor with a crown-capped extracellular domain.
  236. (2003). WWW Service at the European Bioinformatics Inscho

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.